HPLC method for enantioselective analysis of cloprostenol

Development of a Novel Vaginal Drug Delivery System to Control Time of Farrowing and Allow Supervision of Piglet Delivery

The swine industry has evolved significantly in the recent decades, but this has come at considerable expense to piglet survival. Breeding sows for greater prolificacy has been accompanied by a greater proportion of piglets being born underweight, of lower vigor, and higher susceptibility to early mortality. Inducing sows to farrow during working hours has the potential to increase piglet survivability, but non-therapeutic injectable products are often discouraged on farms. We aimed to design and develop a novel vaginal drug delivery system (NVDDS) that could reliably trigger luteolysis and induce parturition. To achieve this, two vaginal tablets containing the luteolytic agent cloprostenol were formulated to be inserted together: one would release constituents immediately on insertion (immediate release; IR) and the other would release cloprostenol in a controlled manner (controlled release; CR). The two formulations (IR and CR) were evaluated for drug release, swelling and bio-adhesion in conditions simulating the sow vaginal environment. The IR tablet released the drug completely for 5 min whereas the CR tablet took 5 h to release 50% of the drug. Furthermore, the release kinetics were evaluated by fitting the dissolution profiles into different mathematical models. Both IR and CR tablets were best fitted by the Makoid–Banakar model which assumes release by summation of different mechanisms. The performance of the optimized formulations was studied in vivo with 161 Large White x Landrace sows of varying parity (0–5). The sows were assigned to five groups. Group 1 (SI) received a single vulval injection of cloprostenol at 0700 h (n = 32), group 2 (SDI) received the same dose split in two parts, at 0700h and 1300h (n = 33). Group 3 (IRT) animals were administered an IR tablet at 0700h (n = 32), while group 4 (IRCRT) received both IR and CR tablets at 0700 h (n = 33). Group 5 was untreated and served as a control (n = 32). The interval to farrowing was longer (p < 0.001) for controls than for treated sows, but there were no differences among cloprostenol treatments for timing of farrowing. The finding confirms the efficacy of the NVDDS for induction of farrowing in sows.

Enantioseparation of cloprostenol on the polysaccharide chiral stationary phase: Influence of the mobile phase on enantioselective adsorption

Cloprostenol (CLO) is an important chiral drug widely used in veterinary practice. In high-performance liquid chromatography (HPLC), the acetonitrile/water system is more effective in the chiral resolution of CLO. The change in the ratio of acetonitrile and water has a great influence on the chiral selectivity of CLO. The enantioselective adsorption and nonselective adsorption of CLO on the polysaccharide stationary phase with three groups of mobile phases (Acetonitrile / 0.1 TFA; 95 Acetonitrile/5 H₂O/0.1 TFA; 45 Acetonitrile/55 H₂O/0.1 TFA) were determined and fitted with the subtraction fitting method (SFM). Adding a small amount of water to the mobile phase mainly reduced the enantioselective equilibrium adsorption constants K_s of (-)-CLO and thus changed the selectivity. Among them, the true separation factor (α_true) of the 95 Acetonitrile/5 H₂O mobile phase was as high as 92.86. Chiral preparation was performed on the basis of this mobile phase. The preparation performance in kkd (kilograms per kilogram of stationary phase purified compound per day) was 0.25 kg racemate/kg CSP/day.